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Abstract: To the best of the authors knowledge, there is little structural data avail-
able on the AGAAAAGA palindrome in the hydrophobic region (113-120) of prion
proteins due to the unstable, noncrystalline and insoluble nature of the amyloid fibril,
although many experimental studies have shown that this region has amyloid fibril
forming properties and plays an important role in prion diseases. In view of this, the
present study is devoted to address this problem from computational approaches such
as local optimization steepest descent, conjugate gradient, discrete gradient and New-
ton methods, global optimization simulated annealing and genetic algorithms, canonical
dual optimization theory, and structural bioinformatics. The optimal atomic-resolution
structures of prion AGAAAAGA amyloid fibils reported in this Chapter have a value
to the scientific community in its drive to find treatments for prion diseases or at least
be useful for the goals of medicinal chemistry.
Key words: Amyloid Fibrils; Prion AGAAAAGA Palindrome; Atomic-resolution
Structures.
1 INTRODUCTION
Prion diseases are invariably fatal and highly infectious neurodegenerative diseases that
affect humans and animals. Prion diseases are amyloid fibril diseases. Prion amyloid fib-
rils are believed rich in β-sheet structure and contain a cross-β core. Many experimental
works [1, 2, 3, 6, 7, 8, 9, 11, 13] show that the hydrophobic region AGAAAAGA of prion
proteins (113-120) plays an important role in the conversion of amyloid fibrils. PrP
lacking / deleting the palindrome (PrP 113-120) neither converted to PrPSc(infectious
prion) nor generated proteinase K-resistant PrP [2, 6, 11, 13]. Brown et al. [1, 3]
pointed out that the AGAAAAGA peptide was found to be necessary (though not
sufficient) for blocking the toxicity and amyloidogenicity of PrP 106-126. The peptide
AGAA did not form fibrils but the peptide AGAAAAGA formed fibrils in both wa-
ter and PBS [1]. Thus, the minimum sequence necessary for fibril formation should be
AGAAA, GAAAA, AAAAG, AAAGA, AGAAAA, GAAAAG, AAAAGA, AGAAAAG,
GAAAAGA or AGAAAAGA. According to Brown [1], AGAAAAGA is important for
fibril formation and is an inhibitor of PrPSc neurotoxicity.
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In theory, for the sake of clarity, we use a program in Zhang et al. [16] to confirm
that prion AGAAAAGA (113-120) segment has an amyloid fibril forming property.
The theoretical computation results are shown in Fig. 1, from which we can see that
prion AGAAAAGA (113-120) region is clearly identified as the amyloid fibril formation
region because the energy is less than the amyloid fibril formation threshold energy -26
[16].
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Figure 1: Prion AGAAAAGA (113-120) is clearly identified as fibril formation segment.
However, due to the unstable, noncrystalline and insoluble nature of the amyloid
fibril, to date structural information on AGAAAAGA region (113-120) has been very
limited. This region falls just within the N-terminal unstructured region PrP (1-123)
of prion proteins. Traditional X-ray crystallography and nuclear magnetic resonance
(NMR) spectroscopy experimental methods cannot be used to get its structural in-
formation. Under this background, computational approaches or introducing novel
mathematical formulations and physical concepts into molecular biology can signif-
icantly stimulate the development of biological and medical science. The author has
introduced novel mathematical global and local optimization computational approaches
to produce the atomic-resolution structures of prion (113-120) AGAAAAGA amyloid
fibrils, which are in Section 2. Section 3 summarizes this article.
2
2 COMPUTATIONALOPTIMIZATIONAPPROACHES
AND THEIR AGAAAAGA STRUCTURAL RESULTS
In 2007, Sawaya et al. got a breakthrough finding: the atomic structures of all amy-
loid fibrils revealed steric zippers, with strong vdw interactions (LJ) between β-sheets
and hydrogen bonds (HBs) to maintain the β-strands [12]. In this section, we will
use suitable templates 2OMP.pdb (the LYQLEN peptide derived from human in-
sulin residues 1318), 1YJP.pdb (the GNNQQNY peptide from the yeast prion protein
Sup35), 3FVA.pdb (NNQNTF 173-178 segment from elk prion protein), 3NHC.pdb
(GYMLGS segment 127-132 from human prion with M129), 3NVE.pdb (MMHFGN
segment 138-143 from Syrian Hamster prion), 3NVF.pdb (IIHFGS segment 138-143
from human prion), 3NVG.pdb (MIHFGN segment 137-142 from mouse prion) and
3NVH.pdb (MIHFGND segment 137-143 from mouse prion) from the Protein Data
Bank (http://www.rcsb.org/) to construct some amyloid fibril models for the prion
AGAAAAGA region (113-120).
2.1 2OMP, 1YJP MODELS
The author used the unmerge, mutate, and merge modules of Insight II (http://accelrys.com/)
for 2OMP.pdb, 1YJP.pdb to build the 12-chain AGAAAA 2OMP-Model (MODEL01),
10-chain AGAAAAG 1YJP-Model (MODEL02), and 10-chain GAAAAGA 1YJP-Model
(MODEL03) [14]. Then, using AMBER 10 [4], the MODEL01-03 were refined by the
hybrid of steepest descent (SD) and conjugate gradient (CG) – simulated annealing
(SA) – SDCG methods, where SA phase made the MODEL01-03 reach sufficient equi-
libration and stability. MODEL1 (Fig. 2) belongs to models of Class 7 (β-strand
antiparallel, face=back, upup) of [12], and MODEL02-03 (Fig. 2) belong to models of
Class 1 (β-strand parallel, face-to-face, upup) of [12].
Sawaya et al. [12] proposed eight classes of steric zipper structures for peptide
segments of fibril forming proteins. For each Class, Zhang [14] constructed the molec-
ular structures for the hydrophobic region AGAAAAGA palindrome of prion proteins
(113120). Besides the above successful MODEL01-03, the unsuccessful molecular mod-
eling experiences are: (1) For Class 1, based on the NNQQNY peptide from yeast
prion protein Sup35 (1YJO.pdb), a hexamer model with six AAAAGA chains can be
constructed by SDCG but cannot pass SA; (2) For Class 2 (i.e. β-strand parallel,
face-to-back, up-up), a tetramer model with four AGAAAA chains can be constructed
basing on the SNQNNF peptide of human prion 170175 (2OL9.pdb) by SDCG but
cannot pass SA; (3) For other Classes (yeast Sup35 GNNQQNY form 2, 2OMM.pdb;
yeast Sup35 NNQQ form 1, 2ONX.pdb; yeast Sup35 NNQQ form 2, 2OLX.pdb; hu-
man insulin VEALYL, 2OMQ.pdb; human Tau protein VQIVYK, 2ON9.pdb; human
Aβ GGVVIA, 2ONV.pdb; human Aβ MVGGVV form 1, 2ONA.pdb; human Aβ MVG-
GVV form 2, 2OKZ.pdb; bovine RNase SSTSAA, 2ONW.pdb) in Sawaya et al. [12],
the β-sheet structure of prion AGAAAAGA palindrome cannot pass the SDCG phase.
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2.2 3FVA MODELS
Instead of using Insight II, Zhang et al. used the mutate module of the free pack-
age Swiss-PdbViewer (SPDBV Version 4.01) (http://spdbv.vital-it.ch) and the hybrid
discrete gradient (DG) simulated annealing method (i.e. DGSA) to build the prion
AGAAAAGA amyloid fibril models [15]. The models were built based on the template
3FVA.pdb of NNQNTF segment from elk prion protein (173-178). After the models
were built, the refinements were done completely same as [14]. A six chains AGAAAA
model could not successfully pass SA of Amber 10. However, two prion AGAAAAGA
palindrome amyloid fibril models (Fig. 3) - a six chains GAAAAG model (MODEL04)
and a six chains AAAAGA model (MODEL05) - were successfully obtained. Compared
with [14], the variations of RMSD, PRESS, and VOLUME (DENSITY) of the 4,400
ps’ equilibration at 100 K are larger [15]; this might imply that DGSA is a little worse
than Insight II.
2.3 3NHC, 3NVE/F/G/H MODELS
Replacing the DGSA of Subsection 2.2, in this Subsection we will use any optimiza-
tion solver, which can accurately solve an optimization problem with 3 or 6 variables,
to build the models; thus the methods in this subsection are very simple and general
for any problems in molecular modeling research area. The model building templates
are: 3NHC.pdb (GYMLGS segment 127-132 from human prion with M129), 3NVE.pdb
(MMHFGN segment 138-143 from Syrian Hamster prion), 3NVF.pdb (IIHFGS segment
138-143 from human prion), 3NVG.pdb (MIHFGN segment 137-142 from mouse prion),
and 3NVH.pdb (MIHFGND segment 137-143 from mouse prion). The mathematical
theory is described as follows.
The atomic structures of all amyloid fibrils revealed steric zippers, with strong
vdw interactions (LJ) between β-sheets and hydrogen bonds (HBs) to maintain the β-
strands [12]. In mathematics, the potential energy mathematical formula for the vdw
interactions between β-sheets is
VLJ(r) =
A
r12
−
B
r6
, (1)
and the potential energy mathematical formula for the HBs between the β-strands is
VHB(r) =
C
r12
−
D
r10
, (2)
where A,B,C,D are constants given. When VLJ and VHB are reaching their minimal
values, the amyloid fibril structures should be in a most stable state. This is a molecular
distance geometry problem (MDGP) [5], which arises in the interpretation of NMR data
and in the determination of protein structure [as an example to understand MDGP, the
problem of locating sensors in telecommunication networks is a DGP. In such a case, the
positions of some sensors are known (which are called anchors) and some of the distances
between sensors (which can be anchors or not) are known: the DGP is to locate the
positions of all the sensors. Here we look sensors as atoms and their telecommunication
network as a molecule]. The three dimensional structure of a molecule with n atoms can
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be described by specifying the 3-Dimensional coordinate positions x1, x2, . . . , xn ∈ R
3
of all its atoms. Given bond lengths dij between a subset S of the atom pairs, the
determination of the molecular structure is
(P0) to find x1, x2, . . . , xn s.t. ||xi − xj || = dij , (i, j) ∈ S, (3)
where || · || denotes a norm in a real vector space and it is calculated as the Euclidean
distance 2-norm in this paper. (3) can be reformulated as a mathematical global opti-
mization problem (GOP)
(P) minP (X) =
∑
(i,j)∈S wij(||xi − xj ||
2 − d2ij)
2 (4)
in the terms of finding the global minimum of the function P (X), where wij , (i, j) ∈ S
are positive weights, X = (x1, x2, . . . , xn)
T ∈ Rn×3 [10] and usually S has many fewer
than n2/2 elements due to the error in the theoretical or experimental data [17, 5].
There may even not exist any solution x1, x2, . . . , xn to satisfy the distance constraints
in (3), for example when data for atoms i, j, k ∈ S violate the triangle inequality; in
this case, we may add a perturbation term −ǫTX to P (X):
(Pǫ) minPǫ(X) =
∑
(i,j)∈S wij(||xi − xj ||
2 − d2ij)
2 − ǫTX, (5)
where ǫ ≥ 0. So, the molecular model building problem is a problem to get an global
minimal solution of (5). Specially, for the amyloid fibril molecular modeling problem,
we find after mutations the hydrogen bonds between β-strands are still maintained but
the vdw contacts become very far. Thus, the dij in (5) should be the sum of vdw radii
of atoms i and j.
After mutations of 3NHC.pdb, 3NVE/F/G/H.pdb by Swiss-PdbViewer, we find
the following least vdw contacts should be maintained respectively for the 3NHC,
3NVE/F/G/H models. 3NHC: A.ALA3.CB-G.ALA4.CB, B.ALA4.CB-H.ALA3.CB
(A.ALA3.CB and B.ALA4.CB (two anchors) and G.ALA4.CB and H.ALA3.CB (two
sensors), MODEL06-08). 3NVE: A.ALA4.CB-G.ALA3.CB, B.ALA4.CB-G.ALA3.CB
(MODEL09), or A.ALA4.CB-G.ALA3.CB, A.ALA2.CB-G.ALA3.CB (MODEL10-11).
3NVF: A.GLY2.CA-H.GLY2.CA, A.ALA4.CB-H.GLY2.CA (MODEL12), A.ALA4.CB-
H.ALA2.CB, A.ALA2.CB-H.ALA2.CB, A.ALA2.CB-H.ALA4.CB (MODEL13-14). 3NVG:
A.GLY2.CA-H.GLY2.CA, A.GLY2.CA-H.ALA4.CB, A.ALA4.CB-H.GLY2.CA (MODEL15),
A.ALA2.CB-H.ALA2.CB, A.ALA2.CB-H.ALA4.CB, A.ALA4.CB-H.ALA2.CB (MODEL16-
17). 3NVH: A.ALA4.CB-H.ALA4.CB (MODEL18-19). We look at the former as an-
chor(s) and its partner as sensor(s). Thus in (5) the variables are 3 or 6 and its dual
variables are 1 or 2 or 3. Any optimization solver should be able to accurately solve the
prion AGAAAAGA amyloid fibril model building problem. Then the MODEL06-19
will be refined by the SDCG optimization program of Amber 10 and the perfect 3NHC,
3NVE/F/G/H prion AGAAAAGA amyloid fibril 3NHC, 3NVE/F/G/H models were
got (Fig.s 4-8).
3 CONCLUSION
Whenever traditional X-ray crystallography and NMR spectroscopy experimental meth-
ods cannot be used to get any structural information of proteins, computational ap-
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proaches or introducing novel mathematical formulations and physical concepts into
molecular biology can significantly stimulate the development of biological and medi-
cal science. The numerous optimal atomic-resolution structures of prion AGAAAAGA
amyloid fibils reported in Fig.s 2-8 have a value to the scientific community in its drive
to find treatments for prion diseases or at least be useful for the goals of medicinal
chemistry.
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Figure 2: MODEL01 - MODEL03 for prion (113-120) AGAAAAGA amyloid fibrils.
Figure 3: MODEL04 - MODEL05 for prion (113-120) AGAAAAGA amyloid fibrils.
Figure 4: MODEL06 - MODEL08 for prion (113-120) AGAAAAGA amyloid fibrils.
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Figure 5: MODEL09 - MODEL11 for prion (113-120) AGAAAAGA amyloid fibrils.
Figure 6: MODEL12 - MODEL14 for prion (113-120) AGAAAAGA amyloid fibrils.
Figure 7: MODEL15 - MODEL17 for prion (113-120) AGAAAAGA amyloid fibrils.
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Figure 8: MODEL18 - MODEL19 for prion (113-120) AGAAAAGA amyloid fibrils.
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